BE563406A - - Google Patents
Info
- Publication number
- BE563406A BE563406A BE563406DA BE563406A BE 563406 A BE563406 A BE 563406A BE 563406D A BE563406D A BE 563406DA BE 563406 A BE563406 A BE 563406A
- Authority
- BE
- Belgium
- Prior art keywords
- parts
- caffeine
- purines
- sodium
- molecular
- Prior art date
Links
- CJUUXVFWKYRHAR-UHFFFAOYSA-M 1-Naphthaleneacetic acid sodium salt Chemical compound [Na+].C1=CC=C2C(CC(=O)[O-])=CC=CC2=C1 CJUUXVFWKYRHAR-UHFFFAOYSA-M 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 10
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims 7
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 5
- 229960001948 caffeine Drugs 0.000 claims 5
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 150000003212 purines Chemical class 0.000 claims 4
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims 4
- 229960000278 theophylline Drugs 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 230000008020 evaporation Effects 0.000 claims 2
- 238000001704 evaporation Methods 0.000 claims 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 2
- 229960004559 theobromine Drugs 0.000 claims 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 claims 1
- 210000000621 bronchi Anatomy 0.000 claims 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 239000002085 irritant Substances 0.000 claims 1
- 231100000021 irritant Toxicity 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 210000004400 mucous membrane Anatomy 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 238000005192 partition Methods 0.000 claims 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims 1
- 235000010234 sodium benzoate Nutrition 0.000 claims 1
- 239000004299 sodium benzoate Substances 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229940075420 xanthine Drugs 0.000 claims 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE563406A true BE563406A (cs) |
Family
ID=184651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE563406D BE563406A (cs) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE563406A (cs) |
-
0
- BE BE563406D patent/BE563406A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1006227A3 (fr) | Inhibiteurs mixtes de la no synthase et de la cyclooxygenase, un procede pour leur preparation et des compositions therapeutiques les contenant. | |
| EP0079464A1 (en) | Thiazolidine-4-carboxylic-acid derivative, process for its preparation and pharmaceutical compositions containing it | |
| WO1998045269B1 (fr) | Derives de quinoleines en tant qu'inhibiteurs de la vih integrase | |
| JPH02255652A (ja) | ベンゼンスルホンアミド類およびその製造方法 | |
| BE563406A (cs) | ||
| CH670448A5 (cs) | ||
| FR2556727A1 (fr) | Nouvelles compositions therapeutiques a base d'adn a haut poids moleculaire et leur procede de preparation | |
| CA1246597A (fr) | Derive de l'acide acetylsalicylique, sa preparation et les compositions pharmaceutiques qui le contiennent | |
| EP0575481B1 (fr) | Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4 | |
| FR2550530A1 (fr) | Derives 2',4'-difluoro-4-hydroxy-(1,1'-biphenyl)-3-carboxyliques de la n-acetyl-cysteine et s-carboxymethyl-cysteine a activite anti-inflammatoire et mucolytique, leur procede de preparation et compositions pharmaceutiques correspondantes | |
| US2363549A (en) | Therapeutic agent for the treatment of hypertension | |
| SU629208A1 (ru) | Иминоди нтарна кислота в качестве комплексона | |
| CH406194A (fr) | Procédé de préparation de sels stables de diméthylcarboxy-alkylsulfonium | |
| BE464545A (cs) | ||
| BE365387A (cs) | ||
| BE352715A (cs) | ||
| CH408891A (fr) | Procédé de préparation de dérivés organiques du bore | |
| FR2475546A1 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant | |
| McKie | LXXXVI.—Determination of the composition of mixtures of eugenol and iso eugenol benzoates by means of melting points | |
| FR2467847A1 (fr) | Nouveaux derives de l'(hydroxybenzyl)-2 benzimidazole et les compositions pharmaceutiques en contenant | |
| BE552488A (cs) | ||
| BE663929A (cs) | ||
| CH229526A (fr) | Procédé de préparation de la 2-(para-amino-phényl-sulfamido)-pyridyl-5-sulfamide. | |
| BE515059A (cs) | ||
| BE667262A (cs) |